Here are six new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.
- Acetazolamide injection: Avet Pharmaceuticals and Hikma have reported a shortage of its 500-milligram, 1-count vials of acetazolamide sodium lyophilized powder for injection. Avet did not provide a reason for shortage and Hikma has the injection on allocation.
- Desonide lotion: Actavis Pharma has discontinued manufacturing of its 0.5-milligram/1-milliliter presentation of Desown lotion, a topical corticosteroid used in dermatology to treat several skin conditions that involve inflammation, redness, itching or swelling.
- Fluphenazine hydrochloride tablet: Upsher-Smith Laboratories has discontinued manufacturing of its 1-, 2.5-, 5- and 10-milligram fluphenazine hydrochloride tablets, an antipsychotic medication used to treat schizophrenia and other psychotic disorders.
- Ibandronate sodium injection: Apotex and Eugi have reported a shortage of its 1-milligram/milliliter and 3-milliliter prefilled syringe of Ibandronate sodium intravenous solution. The drugmakers did not provide a reason for the shortage. Apotex has the presentations on backorder with an estimated release date of mid-November 2025. Eugia has the syringes on intermittent backorder and will be releasing supplies as they become available.
- Obeticholic acid tablet: Intercept Pharmaceuticals has discontinued its 5- and 10-milligram Ocaliva tablet, a medication used to treat primary biliary cholangitis, a chronic liver disease. The shortage is due to a business decision.
- Pilocarpine hydrochloride tablet: Actavis Pharma has discontinued the manufacturing of its 5- and 7.5-milligram Salagen tablets, a drug primarily used to treat symptoms of dry mouth for Sjogren’s disease or dry mouth following radiation therapy for neck or throat cancers.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
